Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207581 · ClinicalTrials.gov registry record · NA
Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT03207581: Completed NA study, sponsored by Mayo Clinic.
NCT03207581 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207581, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The study will assess the effect of individualized professional coaching for mid-career family medicine and general internal medicine physicians on burnout, job satisfaction, and professional fulfillment.
Interventions
- BEHAVIORAL Professional Coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
What the finished NCT03207581 record still lists
NCT03207581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Professional Coaching is the first listed.
NCT03207581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207581 about?
NCT03207581 is a clinical study titled "Effect of Coaching on Mid-Career Physician Well-Being, Job Satisfaction, and Fulfillment". The study will assess the effect of individualized professional coaching for mid-career family medicine and general internal medicine physicians on burnout, job satisfaction, and professional fulfillment.
What is the current status of trial NCT03207581?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2017-07-18. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT03207581?
The interventions under investigation include: Professional Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT03207581?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03207581's enrollment target sits among peer trials
87 974th of 2000 higher than 1,025 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI